Recent NUWE News
- Nuwellis Announces Pricing of $2.7 Million Public Offering • GlobeNewswire Inc. • 04/26/2024 01:17:51 PM
- Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health • GlobeNewswire Inc. • 04/09/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/11/2024 09:08:24 PM
- Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference • GlobeNewswire Inc. • 03/07/2024 02:08:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 05:02:05 PM
- Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/05/2024 01:00:00 PM
- U.S. Futures Dip, Crude Oil Fluctuates • IH Market News • 03/05/2024 11:05:54 AM
- Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024 • GlobeNewswire Inc. • 02/27/2024 02:00:00 PM
- Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™ • GlobeNewswire Inc. • 02/22/2024 12:58:00 PM
- Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/20/2024 10:06:53 PM
- Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference • GlobeNewswire Inc. • 02/20/2024 01:42:52 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/08/2024 10:19:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 02:07:29 PM
- New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload • GlobeNewswire Inc. • 02/06/2024 02:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/09/2024 10:30:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 02:24:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:25:39 PM
- Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter • GlobeNewswire Inc. • 01/04/2024 08:05:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 09:05:26 PM
- New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients • GlobeNewswire Inc. • 11/28/2023 01:00:00 PM
- Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/14/2023 09:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 03:00:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 01:15:43 PM
- Nuwellis, Inc. Announces Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/07/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 08:15:20 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM